1999
DOI: 10.1038/sj.leu.2401477
|View full text |Cite
|
Sign up to set email alerts
|

Effects of TGF-β on the immune system: implications for cancer immunotherapy

Abstract: Transforming growth factor-␤ (TGF-␤) is a potent regulator of numerous processes including hematopoiesis, cell proliferation, differentiation and activation. TGF-␤ has pleiotropic and profound effects on the immune system and on hematologic malignancies, ie leukemia. It is the most potent immunosuppressor described to date. Evidence exists that the immunosuppressive potential of TGF-␤ is an important promoter of malignant cell growth. This is partly caused by TGF-␤-induced interference with the generation of t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
94
0
2

Year Published

2000
2000
2007
2007

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 145 publications
(98 citation statements)
references
References 53 publications
2
94
0
2
Order By: Relevance
“…Tumor-derived TGF-␤ has been shown to down-regulate the generation of tumorspecific cytotoxic lymphocytes (41)(42)(43) and the secretion of immunoregulatory cytokines by T cells (42). TGF-␤ can be a strong costimulator that promotes a shift toward Th2 polarity in rat activated T cells (44).…”
Section: Discussionmentioning
confidence: 99%
“…Tumor-derived TGF-␤ has been shown to down-regulate the generation of tumorspecific cytotoxic lymphocytes (41)(42)(43) and the secretion of immunoregulatory cytokines by T cells (42). TGF-␤ can be a strong costimulator that promotes a shift toward Th2 polarity in rat activated T cells (44).…”
Section: Discussionmentioning
confidence: 99%
“…4 Tumor cells themselves or tumor-infiltrating immunomodulatory cells sometimes produce immunosuppressive cytokines and mediators such as TGF-, 15 IL-10, 16 and PGE 2 . 17 Cancer cells also inactivate NK cells or T cells directly by expressed on their surface Fas ligand, 18 mucins ( DF3 /MUC1 ), 19 or RCAS1.…”
Section: Discussionmentioning
confidence: 99%
“…During tumorigenesis one of the target genes that is preferentially inactivated due to MSI is transforming growth factor ␤ receptor II (TGF␤RII) (Markowitz et al, 1995;Akiyama et al, 1996). Inactivation of TGF␤RII on cells down-regulates the suppressive function of TGF␤ on cell proliferation and in that way also results in disturbance of growth control (DeVisser and Kast, 1999). Most of the hereditary nonpolyposis colorectal tumors (HNPCC) exhibit MSI, whereas in sporadic colorectal cancers only 3% to 10% show this phenotype.…”
mentioning
confidence: 99%